Endorsement of the TRIPOD statement and the reporting of studies developing contrast-induced nephropathy prediction models for the coronary angiography/percutaneous coronary intervention population: a cross-sectional study

Abstract

ObjectiveClear and specific reporting of a research paper is essential for its validity and applicability. Some studies have revealed that the reporting of studies based on the clinical prediction models was generally insufficient based on the Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) checklist. However, the reporting of studies on contrast-induced nephropathy (CIN) prediction models in the coronary angiography (CAG)/percutaneous coronary intervention (PCI) population has not been thoroughly assessed. Thus, the aim is to evaluate the reporting of the studies on CIN prediction models for the CAG/PCI population using the TRIPOD checklist.DesignA cross-sectional study.MethodsPubMed and Embase were systematically searched from inception to 30 September 2021. Only the studies on the development of CIN prediction models for the CAG/PCI population were included. The data were extracted into a standardised spreadsheet designed in accordance with the ‘TRIPOD Adherence Assessment Form’. The overall completeness of reporting of each model and each TRIPOD item were evaluated, and the reporting before and after the publication of the TRIPOD statement was compared. The linear relationship between model performance and TRIPOD adherence was also assessed.ResultsWe identified 36 studies that developed CIN prediction models for the CAG/PCI population. Median TRIPOD checklist adherence was 60% (34%–77%), and no significant improvement was found since the publication of the TRIPOD checklist (p=0.770). There was a significant difference in adherence to individual TRIPOD items, ranging from 0% to 100%. Moreover, most studies did not specify critical information within the Methods section. Only 5 studies (14%) explained how they arrived at the study size, and only 13 studies (36%) described how to handle missing data. In the Statistical analysis section, how the continuous predictors were modelled, the cut-points of categorical or categorised predictors, and the methods to choose the cut-points were only reported in 7 (19%), 6 (17%) and 1 (3%) of the studies, respectively. Nevertheless, no relationship was found between model performance and TRIPOD adherence in both the development and validation datasets (r=−0.260 and r=−0.069, respectively).ConclusionsThe reporting of CIN prediction models for the CAG/PCI population still needs to be improved based on the TRIPOD checklist. In order to promote further external validation and clinical application of the prediction models, more information should be provided in future studies.

Evaluating the Differential Risk of Contrast-Induced Nephropathy Among Diabetic and Non-diabetic Patients Following Percutaneous Coronary Intervention

“…The risk of contrast-induced nephropathy (CIN) during percutaneous coronary intervention (PCI) is difficult yet significant having an important impact on both patient outcomes and healthcare in general. CIN, for instance, varies greatly, and those with diabetes mellitus (DM) are significantly more prone to suffer from it [ 1 , 2 ]. Mehran et al [ 3 ] and Stone GW et al [ 4 ] conducted pivotal research that provided light on general risk factors and approaches to prevent CIN.…”

The reporting of prognostic prediction models for obstetric care was poor: a cross-sectional survey of 10-year publications

“…In addition, several journals, such as The BMJ and PLOS Medicine, require researchers to include a filled-out checklist of the TRIPOD at the time of submission, while others are encouraged to adhere to the TRIPOD [ 21 ]. Since the release of the TRIPOD, some investigations using the TRIPOD checklist have demonstrated that the reporting quality of prediction models among several clinical domains is suboptimal [ 15 , 22 – 24 ]..…”